Telix Pharmaceutical (TLX)

28/09/2022

Telix Pharmaceutical (TLX)

Subscribe to Market Matters Blog

Latest Reports

Afternoon report 13/08/2026

The Match Out: Reporting season kicks into gear, ASX closes lower

The ASX 200 finished lower, recovering from a decline of around 0.7% earlier in the session as a blockbuster day of reporting continued to drive a highly mixed market. Breadth was weak for much of the day, with the index improving through the afternoon as some of the pressure on the major banks eased.

Morning report 13/08/2026

What Matters Today: Is it time to revisit Defence Stocks after Austal’s takeover bid?

The ASX 200 struggled on Wednesday as reporting season weighed on sentiment and the index; it's only early days, but we’re seeing a very different story emerge locally compared to the recent season in the US. The S&P 500's 2Q26 earnings season is essentially complete and has been strong, while the ASX 200's August reporting season has only just begun, but with less than 10% of companies having faced the music, the early signs are not overly encouraging.